Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an update.
ResMed Inc.’s Chief Financial Officer, Brett Sandercock, has made a transaction involving the sale of 1,000 shares of the company’s common stock at a price of $234.04 per share. This transaction was conducted under a pre-established Rule 10b5-1 plan, indicating a strategic approach to stock management, which may reassure stakeholders about the transparency and governance practices within the company.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, primarily focusing on the development and manufacturing of equipment related to respiratory disorders. The company’s main products include devices for sleep apnea and other chronic respiratory conditions, catering to a global market.
YTD Price Performance: 2.69%
Average Trading Volume: 941,758
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.87B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.
